Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.55% vs 15.94% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 16.70% vs 4.17% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 8.81% vs 23.94% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -0.57% vs -10.44% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Mankind Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.55% vs 15.94% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 20.77% vs 13.05% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 16.70% vs 4.17% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -21.72% vs 30.43% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 8.81% vs 23.94% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 8.75% vs 24.10% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -0.57% vs -10.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 2,289.86% vs -17.63% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






